In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas-Reference-Cited by-同舟云学术

In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas

Published:2017-03-13 Issue:6 Volume:102 Page:2009-2018
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Gatto Federico,Feelders Richard A.,Franck Sanne E.,van Koetsveld Peter M.,Dogan Fadime,Kros Johan M.,Neggers Sebastian J. C. M. M.,van der Lely Aart-Jan,Lamberts Steven W. J.,Ferone Diego,Hofland Leo J.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/102/6/2009/17665245/jc.2017-00135.pdf

Reference34 articles.

1. Medical progress: Acromegaly;N Engl J Med,2006

2. Expert consensus document: a consensus on the medical treatment of acromegaly;Acromegaly Consensus Group;Nat Rev Endocrinol,2014

3. Medical therapy of acromegaly: efficacy and safety of somatostatin analogues;Drugs,2009

4. Octreotide;N Engl J Med,1996

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Response to Medical Treatment in Acromegaly via Granulation Pattern, Expression of Somatostatin Receptors Type 2 and 5 and E-Cadherin;International Journal of Molecular Sciences;2024-08-08

2. Current role of pasireotide in the treatment of acromegaly;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

3. Management of pasireotide-induced hyperglycemia in patients with acromegaly: An experts’ consensus statement;Frontiers in Endocrinology;2024-02-09

4. A novel somatostatin receptor ligand for human ACTH – and GH –secreting pituitary adenomas;European Journal of Endocrinology;2023-12-20

5. Biomarkers of response to treatment in acromegaly;Expert Review of Endocrinology & Metabolism;2023-12-11